Etravirine
Back to searchMolecule Structure
Scientific Name
Etravirine
Description of the Drug
Etravirine is a non-nucleoside reverse transcriptase inhibitor (NNRTI) used in the treatment of HIV-1 infections in combination with other antiretroviral agents.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB06414
http://www.drugbank.ca/drugs/DB06414
Brand Name(s)
Intelence
Company Owner(s)
Carnegie Pharmaceuticals Llc, Janssen Research And Development Llc, Amneal Eu Ltd
Mechanism(s) Of Action
Target Name | Target Type | Action Type | Target ChEMBL ID |
---|---|---|---|
Human immunodeficiency virus type 1 reverse transcriptase | SINGLE PROTEIN | INHIBITOR | CHEMBL247 |
Clinical Trial(s)
Unichem Links
SureChEMBL | SCHEMBL52691 | ||
PharmGKB | PA166014703 | ||
DrugBank | DB06414 | ||
PubChem: Thomson Pharma | 14856802 | ||
PubChem | 193962 | ||
LINCS | LSM-45824 | ||
Nikkaji | J1.588.786I | ||
PDBe | 65B | ||
BindingDB | 50103642 | ||
EPA CompTox Dashboard | DTXSID30181412 | ||
DrugCentral | 1115 | ||
Brenda | 6272 | 135069 | 9938 |
ChemicalBook | CB51509336 | CB11455806 | |
rxnorm | ETRAVIRINE | INTELENCE | |
PubChem: Drugs of the Future | 12015430 | ||
ChEBI | 63589 | ||
ZINC | ZINC000000602632 |